Prevention of inhalational anthrax in the US outbreak
Prevention of inhalational anthrax in the US outbreak
复制标题
DOI:
10.1126/science.1068474
复制
发表时间:
2002-03-08
期刊:
影响因子:
56.9
通讯作者:
Blades, N
中科院分区:
文献类型:
--
作者:
Brookmeyer, R;Blades, N
The anthrax outbreak in the United States in fall 2001 resulted from the intentional dissemination of Bacillus anthracis spores (1). In response to the outbreak, public health authorities recommended that some groups of individuals undergo a 60-day regimen of antimicrobial prophylaxis (AP)(2). There have been no reported cases of inhalational anthrax among persons using AP. We report the results of a statistical analysis to estimate the number of cases of inhalational anthrax that may have been prevented by AP.The first cluster of cases occurred in two employees of a Florida media-publishing company, although neither the likely source of exposure (a contaminated letter) nor the date of exposure has been identified. A second cluster of two cases occurred among postal workers in New Jersey. A third cluster of four cases occurred among postal workers in Washington, DC The source of exposure for the second and third clusters was a contaminated letter (s) sent to a government official (s) in Washington, DC, processed through several postal facilities. The dates of onset of symptoms for the cases from these three clusters have been estimated through epidemiological investigation (3)(Fig. 1A). Three additional cases have been reported that do not fall into these three clusters. Public health officials recommended AP for persons presumptively exposed, which included the following three groups:(i) persons who worked at or visited the media-publishing company in Florida,(ii) workers at two postal facilities in New Jersey,(iii) and workers at a postal facility in Washington, DC A statistical model can be used to estimate the numbers of cases of inhalational anthrax prevented by AP among persons in these three groups using information about dates of exposure, symptom onset, AP, and the incubation period. The key idea is that the observed cases from a group are only a fraction of those that would have occurred, because they are the ones with incubation periods shorter than the time interval between exposure and use of AP. The incubation period distribution, F (t), is the probability of onset of symptoms within t days of exposure if an individual received sufficient dose of spores to cause disease but did not receive AP. If N is the number of individuals who received a sufficient dose of spores to cause disease and X is the number of cases who had disease onset within T days after exposure, at which point exposed individuals began AP, the relation X NF (T) can be used